Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Por um escritor misterioso
Descrição
PDF) Evidence-Based Recommendations for Monitoring Safety of Second Generation Antipsychotics in Children and Youth
Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews
Pharmacology and Therapeutic Potential of the 5-HT7 Receptor
The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone - Pilunthanakul - 2023 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Frontiers Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS
Aripiprazole: a new treatment for schizophrenia
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder
Frontiers Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
Synthesis and Characterization of 5-(2-Fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2
PDF) Important pharmacogenetic information for drugs prescribed during the SARS-CoV-2 infection (COVID-19)
PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial
de
por adulto (o preço varia de acordo com o tamanho do grupo)
